Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Fewtrell

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
EFSA Journal. European Food Safety Authority|July 20, 2023
Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V, Torsten Bohn, Jacqueline Castenmiller, et al.
Kidney International Reports|February 23, 2023
Bone Mineral Density and Vascular Calcification in Children and Young Adults With CKD 4 to 5 or on DialysisAlexander D Lalayiannis, Nicola J Crabtree, Charles J Ferro, et al.
EFSA Journal. European Food Safety Authority|March 14, 2022
Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by HIPP-Werk Georg Hipp OHG (dossier submitted by meyer.science GmbH), Torsten Bohn, Jacqueline Castenmiller, et al.
Annals of Nutrition & Metabolism|June 9, 2012
Documentation of functional and clinical effects of infant nutrition: setting the scene for COMMENTBerthold Koletzko, Hania Szajewska, Margaret Ashwell, et al.
EFSA Journal. European Food Safety Authority|December 14, 2020
Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by Danone Trading ELN B.V, Jacqueline Castenmiller, Stefaan de Henauw, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Appropriate age range for introduction of complementary feeding into an infant's diet, Jacqueline Castenmiller, Stefaan de Henauw, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Scientific Opinion on the safety and suitability for use by infants of follow-on formulae with a protein content of at least 1.6 g/100 kcal, Dominique Turck, Jean-Louis Bresson, et al.
EFSA Journal. European Food Safety Authority|April 1, 2021
Scientific and technical guidance for the preparation and presentation of a dossier for evaluation of an infant and/or follow-on formula manufactured from protein hydrolysates (Revision 1), Dominique Turck, Jean-Louis Bresson, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow-on formula manufactured from protein hydrolysates, Dominique Turck, Jean-Louis Bresson, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Update of the tolerable upper intake level for vitamin D for infants, Dominique Turck, Jean-Louis Bresson, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
EFSA Journal. European Food Safety Authority|July 20, 2023
Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V, Torsten Bohn, Jacqueline Castenmiller, et al.
Kidney International Reports|February 23, 2023
Bone Mineral Density and Vascular Calcification in Children and Young Adults With CKD 4 to 5 or on DialysisAlexander D Lalayiannis, Nicola J Crabtree, Charles J Ferro, et al.
EFSA Journal. European Food Safety Authority|March 14, 2022
Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by HIPP-Werk Georg Hipp OHG (dossier submitted by meyer.science GmbH), Torsten Bohn, Jacqueline Castenmiller, et al.
Annals of Nutrition & Metabolism|June 9, 2012
Documentation of functional and clinical effects of infant nutrition: setting the scene for COMMENTBerthold Koletzko, Hania Szajewska, Margaret Ashwell, et al.
EFSA Journal. European Food Safety Authority|December 14, 2020
Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by Danone Trading ELN B.V, Jacqueline Castenmiller, Stefaan de Henauw, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Appropriate age range for introduction of complementary feeding into an infant's diet, Jacqueline Castenmiller, Stefaan de Henauw, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Scientific Opinion on the safety and suitability for use by infants of follow-on formulae with a protein content of at least 1.6 g/100 kcal, Dominique Turck, Jean-Louis Bresson, et al.
EFSA Journal. European Food Safety Authority|April 1, 2021
Scientific and technical guidance for the preparation and presentation of a dossier for evaluation of an infant and/or follow-on formula manufactured from protein hydrolysates (Revision 1), Dominique Turck, Jean-Louis Bresson, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow-on formula manufactured from protein hydrolysates, Dominique Turck, Jean-Louis Bresson, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Update of the tolerable upper intake level for vitamin D for infants, Dominique Turck, Jean-Louis Bresson, et al.
Pageof 15